A 52-Week, Open-Label, Prospective, Multicenter, International Study of a Transition to the Paliperidone Palmitate 3-Month Formulation in Patients with Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation
2022-06-27
عنوان الدراسة
A 52-Week, Open-Label, Prospective, Multicenter, International Study of a Transition to the Paliperidone Palmitate 3-Month Formulation in Patients with Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation
داعم الدراسة
anssen-Cilag International NV
دواء الدراسة
paliperidone
رقم بروتوكول الدراسة
R092670SCH3015
حالة الدراسة
Completed
موقع الدراسة
JPH
مرحلة الدراسة
3
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。